Multilocus Analysis of Hypertension: A Hierarchical Approach
- 1 April 2004
- journal article
- Published by S. Karger AG in Human Heredity
- Vol. 57 (1) , 28-38
- https://doi.org/10.1159/000077387
Abstract
While hypertension is a complex disease with a well-documented genetic component, genetic studies often fail to replicate findings. One possibility for such inconsistency is that the underlying genetics of hypertension is not based on single genes of major effect, but on interactions among genes. To test this hypothesis, we studied both single locus and multilocus effects, using a case-control design of subjects from Ghana. Thirteen polymorphisms in eight candidate genes were studied. Each candidate gene has been shown to play a physiological role in blood pressure regulation and affects one of four pathways that modulate blood pressure: vasoconstriction (angiotensinogen, angiotensin converting enzyme - ACE, angiotensin II receptor), nitric oxide (NO) dependent and NO independent vasodilation pathways and sodium balance (G protein-coupled receptor kinase, GRK4). We evaluated single site allelic and genotypic associations, multilocus genotype equilibrium and multilocus genotype associations, using multifactor dimensionality reduction (MDR). For MDR, we performed systematic reanalysis of the data to address the role of various physiological pathways. We found no significant single site associations, but the hypertensive class deviated significantly from genotype equilibrium in more than 25% of all multilocus comparisons (2,162 of 8,178), whereas the normotensive class rarely did (11 of 8,178). The MDR analysis identified a two-locus model including ACE and GRK4 that successfully predicted blood pressure phenotype 70.5% of the time. Thus, our data indicate epistatic interactions play a major role in hypertension susceptibility. Our data also support a model where multiple pathways need to be affected in order to predispose to hypertension.Keywords
This publication has 43 references indexed in Scilit:
- The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?BioEssays, 2004
- Peroxisome Proliferator-Activated Receptor (PPAR) α and PPARβ/δ, but not PPARγ, Modulate the Expression of Genes Involved in Cardiac Lipid MetabolismCirculation Research, 2003
- Angiotensinogen Gene Haplotype and HypertensionHypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- exo1-Dependent Mutator Mutations: Model System for Studying Functional Interactions in Mismatch RepairMolecular and Cellular Biology, 2001
- Angiotensinogen Gene Polymorphisms M235T/T174MHypertension, 1999
- Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertensionKidney International, 1998
- Evaluation of the Angiotensinogen Locus in Human Essential HypertensionHypertension, 1998
- Hypertension in mice lacking the gene for endothelial nitric oxide synthaseNature, 1995
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992